Whiteside Theresa L
J Clin Invest. 2016 Apr 1;126(4):1216-23. doi: 10.1172/JCI81136. Epub 2016 Feb 29.
Tumor-derived exosomes (TEX) are harbingers of tumor-induced immune suppression: they carry immunosuppressive molecules and factors known to interfere with immune cell functions. By delivering suppressive cargos consisting of proteins similar to those in parent tumor cells to immune cells, TEX directly or indirectly influence the development, maturation, and antitumor activities of immune cells. TEX also deliver genomic DNA, mRNA, and microRNAs to immune cells, thereby reprogramming functions of responder cells to promote tumor progression. TEX carrying tumor-associated antigens can interfere with antitumor immunotherapies. TEX also have the potential to serve as noninvasive biomarkers of tumor progression. In the tumor microenvironment, TEX may be involved in operating numerous signaling pathways responsible for the downregulation of antitumor immunity.
肿瘤衍生的外泌体(TEX)是肿瘤诱导免疫抑制的先兆:它们携带已知会干扰免疫细胞功能的免疫抑制分子和因子。通过将由与亲代肿瘤细胞中相似的蛋白质组成的抑制性货物传递给免疫细胞,TEX直接或间接影响免疫细胞的发育、成熟和抗肿瘤活性。TEX还将基因组DNA、mRNA和微小RNA传递给免疫细胞,从而重新编程反应细胞的功能以促进肿瘤进展。携带肿瘤相关抗原的TEX可干扰抗肿瘤免疫疗法。TEX也有潜力作为肿瘤进展的非侵入性生物标志物。在肿瘤微环境中,TEX可能参与运作许多负责下调抗肿瘤免疫力的信号通路。